
亚太地区血管内超声 (IVUS) 设备市场预测至 2028 年 - COVID-19 影响和按模式(虚拟组织学 IVUS、iMap IVUS 和集成反向散射 IVUS)、产品(设备和配件 [导管、导丝等] 进行区域分析) )和最终用户(医院和诊所、诊断中心以及学术和研究机构)
No. of Pages: 148 | Report Code: TIPRE00028764 | Category: Life Sciences
No. of Pages: 148 | Report Code: TIPRE00028764 | Category: Life Sciences
市场增长归因于普及率上升冠状动脉疾病和增加研发活动以及改善医疗基础设施。然而,IVUS 的召回限制了市场增长。
领先的市场参与者通过扩大分销网络和增强制造能力来提高其在新兴市场的渗透率。韩国和印度的新兴市场预计将为提供关键血管内超声设备的公司提供潜在的增长机会。这可能与这些国家庞大的患者群体、高心血管疾病患病率、可支配收入的增加、医疗基础设施的改善以及医疗旅游业的发展有关。
由于法规和数据要求相对宽松,亚太地区已成为一个商业友好且富有弹性的中心。随着美国和欧洲市场的成熟,大多数参与者将注意力转移到新兴市场。市场主体加大对新兴国家的投资对于这些国家的技术升级发挥着至关重要的作用。例如,2021年12月,Conavi Medical Inc.签订了价值2000万美元的融资协议,以支持其创新血管内图像引导技术的商业化。因此,新兴经济体不断增长的潜力支持了CVD诊断的倾向。
世界各地的各个经济体,例如日本、中国、印度和韩国,正在大力实现医疗保健现代化设施和服务。结果,这些国家人民的预期寿命增加,导致老年人口基数增加。年龄是心血管疾病发生的一个重要危险因素。心脏的生理老化、氧化应激和炎症的增加是导致CVD发生和表现的主要因素。因此,老年人口的增加凸显了对血管内超声设备(IVUS)的需求。
供应链的中断以及对有效治疗新冠肺炎疗法的巨大需求-19将亚太地区的医疗保健研究行业置于至关重要的地位。已采取禁止措施来遏制 SARS-CoV-2 的传播。 2020 年,癌症筛查、诊断和治疗要么推迟,要么延迟,优先考虑新冠患者,这阻碍了对血管内超声 (IVUS) 设备的需求。此外,该地区许多国家还面临通货膨胀、GDP负增长和失业等问题。疫情影响了全球经济的三个主要方面:制造业、供应链、商业和金融市场。医疗器械制造商和供应商正在将重点转向开发和供应用于呼吸系统疾病的 COVID-19 必需品和医疗器械。患有高血压、糖尿病、心血管疾病等的患者比没有患有任何重大疾病的人更容易感染新型冠状病毒。研究人员越来越多地投入时间和资源来了解床旁超声在当前流行病中的作用,特别是对于透析患者。虽然未来几年研发活动可能会加快步伐,但医疗器械市场参与者预计将解决在严格的贸易和运输限制下阻碍供应链的问题。
亚太地区血管内超声 (IVUS) 设备市场细分 span>
Strategic insights for Asia Pacific Intravascular Ultrasound (IVUS) Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 138.26 Million |
Market Size by 2028 | US$ 237.06 Million |
Global CAGR (2021 - 2028) | 8.0% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 模式
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Intravascular Ultrasound (IVUS) Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Intravascular Ultrasound (IVUS) Devices Market is valued at US$ 138.26 Million in 2021, it is projected to reach US$ 237.06 Million by 2028.
As per our report Asia Pacific Intravascular Ultrasound (IVUS) Devices Market, the market size is valued at US$ 138.26 Million in 2021, projecting it to reach US$ 237.06 Million by 2028. This translates to a CAGR of approximately 8.0% during the forecast period.
The Asia Pacific Intravascular Ultrasound (IVUS) Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Intravascular Ultrasound (IVUS) Devices Market report:
The Asia Pacific Intravascular Ultrasound (IVUS) Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Intravascular Ultrasound (IVUS) Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Intravascular Ultrasound (IVUS) Devices Market value chain can benefit from the information contained in a comprehensive market report.